This page is part of the FHIR Specification v4.1.0: R4B Ballot. About the R4B version of FHIR. The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4
Pharmacy Work Group | Maturity Level: 1 | Draft | Use Context: Any |
This is a value set defined by the FHIR project.
Summary
Defining URL: | http://hl7.org/fhir/ValueSet/reason-medication-status-codes |
Version: | 4.1.0 |
Name: | SNOMEDCTDrugTherapyStatusCodes |
Title: | SNOMED CT Drug Therapy Status codes |
Definition: | This value set includes some taken and not taken reason codes from SNOMED CT - provided as an exemplar |
Committee: | Pharmacy Work Group |
OID: | 2.16.840.1.113883.4.642.3.369 (for OID based terminology systems) |
Copyright: | This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement |
Source Resource | XML / JSON |
This value set is used in the following places:
This value set includes codes based on the following rules:
http://snomed.info/sct
where concept is-a 266710000 (Drugs not taken/completed)http://snomed.info/sct
where concept is-a 410684002 (Drug therapy status)
This expansion generated 11 Mar 2021
This value set contains 190 concepts
Expansion based on SNOMED CT International edition 31-Jan. 2020
All codes from system http://snomed.info/sct
Code | Display | Definition |
266710000 | Drugs not taken/completed | |
182862001 | Drug not taken - dislike taste | |
182863006 | Drug not taken - dislike form | |
182864000 | Drug not taken - side-effects | |
182865004 | Drug not taken - inconvenient | |
182868002 | Treatment stopped - alternative therapy undertaken | |
182869005 | Drug not taken - patient lost tablets | |
182870006 | Drug discontinued - reason unknown | |
182871005 | Drug discontinued - patient fear/risk | |
182872003 | Drug discontinued - too expensive | |
182873008 | Drug treatment stopped - patient ran out of tablets | |
182874002 | Treatment stopped - patient unable to concentrate | |
266711001 | Drug not taken - problem swallowing | |
275929009 | Tablets too large to swallow | |
410684002 | Drug therapy status | |
134390006 | Angiotensin converting enzyme inhibitor not indicated | |
134397009 | Angiotensin converting enzyme inhibitor declined | |
135794007 | Drug indicated | |
135795008 | Nitrate indicated | |
135796009 | Calcium channel blocker indicated | |
135798005 | Diuretic indicated | |
135799002 | Angiotensin converting enzyme inhibitor indicated | |
135800003 | Aspirin indicated | |
135801004 | Beta blocker indicated | |
135803001 | Warfarin indicated | |
161646004 | H/O: high risk medication | |
161647008 | H/O: anticoagulant therapy | |
161648003 | H/O: steroid therapy | |
161649006 | H/O: insulin therapy | |
161650006 | H/O: anticonvulsant therapy | |
161652003 | H/O: hormone replacement (HRT) | |
161653008 | H/O: chemotherapy | |
170622002 | Oral steroids started | |
170624001 | Oral steroids stopped | |
170688000 | Lithium stopped | |
170689008 | Injectable phenothiazine stopped | |
170821007 | B12 injections started | |
170826002 | B12 injections stopped | |
170919001 | Warfarin therapy stopped | |
170954008 | HRT contraindicated | |
170955009 | HRT started | |
170958006 | HRT stopped | |
182834008 | Drug course completed | |
182840001 | Drug treatment stopped - medical advice | |
182841002 | Dr stopped drugs - ineffective | |
182842009 | Doctor stopped drugs - side effect | |
182843004 | Dr stopped drugs -inconvenient | |
182844005 | Doctor stopped drugs - patient dislikes | |
182845006 | Doctor stopped drugs - avoid interaction | |
182846007 | Doctor stopped drugs - medical aim achieved | |
274512008 | Drug therapy discontinued | |
309841001 | Thyroxine treatment stopped | |
312451002 | Aspirin prophylaxis contra-indicated | |
315023008 | Aspirin prophylaxis refused | |
315062004 | Beta blocker contraindicated | |
315364008 | Angiotensin converting enzyme inhibitors contraindicated | |
390914001 | Thrombolytic therapy refused | |
391158008 | Antibiotic prophylaxis recommended | |
391159000 | Antibiotic prophylaxis not recommended | |
394888000 | Hormone replacement therapy requested | |
394987009 | Angiotensin II receptor antagonists contraindicated | |
395006008 | Medication stopped - interaction | |
395007004 | Medication stopped - ineffective | |
395008009 | Medication stopped - contra-indication | |
395009001 | Medication stopped - side effect | |
401084003 | Angiotensin II receptor antagonist declined | |
401244004 | H/O: prolonged corticosteroid therapy | |
407572003 | Angiotensin II receptor antagonist not indicated | |
408339001 | Thrombolysis therapy not indicated | |
408354007 | Drug treatment still needed | |
408355008 | Drug treatment no longer needed | |
412782003 | Inappropriate medication stopped | |
413555000 | Antibiotic prophylaxis indicated | |
413558003 | Anticoagulation contraindicated | |
413559006 | Anticoagulation declined | |
413560001 | Anticoagulation not indicated | |
416404000 | Angiotensin converting enzyme inhibitor target dose not achieved | |
417576009 | Deferred antibiotic therapy | |
430279008 | Drug treatment stopped at end of clinical trial | |
438553004 | H/O: drug therapy | |
439631004 | H/O: statin therapy | |
440935004 | H/O: beta blocker therapy | |
440991005 | H/O: nitrate therapy | |
441186000 | H/O: antiplatelet agent therapy | |
441195008 | H/O: angiotensin converting enzyme (ACE) inhibitor therapy | |
441196009 | H/O: angiotensin II receptor antagonist therapy | |
441899004 | History of therapy with ototoxic medication | |
473151000 | History of tuberculosis chemotherapy | |
698428006 | Angiotensin II receptor antagonist indicated | |
698449007 | Antibiotic therapy indicated | |
698459008 | Antidepressant drug treatment stopped | |
698460003 | Antiviral therapy declined | |
698468005 | Bisoprolol contraindicated | |
698758004 | Nebivolol therapy refused | |
698985001 | Long term dual antiplatelet drug therapy indicated | |
699008007 | History of fenfluramine therapy | |
699137009 | Carvedilol therapy declined | |
700110004 | Bisphosphonate prophylaxis suspended | |
700384008 | Antibiotic prophylaxis not indicated | |
702542006 | Incretin mimetic therapy started | |
703989007 | Teriparatide therapy declined | |
703991004 | Raloxifene therapy declined | |
703996009 | Teriparatide not indicated | |
703997000 | Teriparatide contraindicated | |
703999002 | Raloxifene contraindicated | |
704000000 | Raloxifene not indicated | |
704033005 | Phosphodiesterase 5 inhibitor not indicated | |
704047009 | Phosphodiesterase 5 inhibitor declined | |
707298000 | Phosphodiesterase-5 inhibitor contraindicated | |
708000007 | Insulin treatment stopped | |
710159007 | Long-term current use of immunosuppressive drug | |
710814002 | Long-term current use of drug therapy | |
710815001 | Long-term current use of insulin | |
710816000 | Long-term current use of steroid | |
710817009 | Long-term current use of inhaled steroid | |
711149003 | Long-term current use of antibiotic | |
711150003 | Long-term current use of anticoagulant | |
711370000 | Oral steroids used since last encounter | |
711436000 | Inhaled steroids used daily | |
712985002 | Chemotherapy not done | |
720971004 | Insulin declined | |
721872002 | Antifungal therapy indicated | |
722480002 | Chemotherapy started | |
736004008 | Nebivolol contraindicated | |
736006005 | Carvedilol contraindicated | |
736799004 | Beta blocker target dose not achieved | |
763323007 | Hormone replacement therapy refused | |
764639002 | Antidepressant drug treatment started | |
787928003 | Coagulation factor Xa inhibitor prophylaxis indicated | |
787930001 | Direct thrombin inhibitor prophylaxis indicated | |
7611000175100 | Dipyridamole contraindicated | |
7861000175101 | Antiplatelet therapy contraindicated | |
53081000119101 | Long-term current use of testosterone replacement therapy | |
61251000119108 | Long-term current use of tacrolimus | |
61261000119105 | Long-term current use of sirolimus | |
69521000119101 | Long-term current use of thyroid hormone replacement therapy | |
98001000119105 | Long-term current use of anticonvulsant | |
106511000119106 | Long-term current use of mycophenolate | |
106521000119104 | Long-term current use of cyclophosphamide | |
106571000119103 | Long-term current use of sulfasalazine | |
106581000119100 | Long-term current use of cyclosporine | |
106631000119102 | Long-term current use of infliximab | |
106691000119103 | Long-term current use of etanercept | |
106701000119103 | Long-term current use of leflunomide | |
113481000119108 | Long-term current use of tamoxifen | |
113521000119108 | Long term current use of adalimumab therapy | |
113531000119106 | Long term current use of abatacept | |
113541000119102 | Long-term current use of rituximab | |
117431000119101 | Long term current use of drug therapy for attention deficit hyperactivity disorder | |
118901000119102 | Long-term current use of erythropoiesis stimulating therapy | |
118911000119104 | Long-term current use of lenalidomide | |
118921000119106 | Long-term current use of clozapine | |
118931000119109 | Long-term current use of intravenous immune globulin | |
122621000119109 | Prophylactic anticoagulation given | |
126951000119109 | Long-term current use of lithium | |
127721000119100 | Long-term current use of testosterone cypionate | |
130721000119103 | Long-term current use of golimumab | |
131531000119103 | Long-term current use of aspirin | |
133621000119103 | Long term current use of non-steroidal anti-inflammatory drug | |
134651000119108 | History of estrogen therapy | |
134671000119104 | History of systemic steroid therapy | |
139181000119106 | Long-term current use of amiodarone | |
140301000119107 | Long-term current use of hydroxychloroquine | |
140561000119102 | Long-term current use of azathioprine | |
150881000119107 | Long-term current use of postmenopausal hormone replacement therapy | |
328941000119101 | Long-term current use of bisphosphonates | |
329061000119105 | Long-term current use of belimumab | |
329071000119104 | Long-term current use of tocilizumab | |
347841000119106 | Long-term current use of cannabis | |
11012701000119107 | Long-term current use of antibiotics for prevention of recurrent infection | |
11012741000119109 | Long-term current use of certolizumab pegol | |
12384021000119106 | Long-term current use of mercaptopurine | |
15625371000119108 | Long-term current use of ustekinumab | |
15625411000119109 | Long-term current use of apremilast | |
15625451000119105 | Long-term current use of tofacitinib | |
15929341000119102 | Long-term current use of antipsychotic medication | |
15929381000119107 | Long-term current use of anxiolytic medication | |
15929421000119103 | Long-term current use of antiviral agent | |
15929461000119108 | Long-term current use of leuprorelin | |
15929581000119100 | Long-term current use of antidepressant medication | |
16234971000119108 | Long-term current use of diuretic | |
16526761000119100 | Long-term current use of secukinumab | |
16659291000119100 | Long-term current use of levothyroxine | |
16755631000119109 | Long-term current use of natalizumab | |
16755671000119107 | Long-term current use of mesalamine | |
16772161000119102 | Long-term current use of vedolizumab | |
16772201000119107 | Long-term current use of everolimus | |
16863441000119108 | Long-term current use of stimulant | |
16863481000119103 | Long-term current use of benzodiazepine | |
70732231000132107 | Duplicate drug therapy stopped |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |